Export licence approved

Company news

01 Jan 2019

Export2

Little Green Pharma is pleased to announce the company has been granted an Export Licence by the Federal Department of Health, effective 15 January 2019. Obtaining this license meets one of Little Green Pharma’s key strategic milestones on the path to become a key domestic and international supplier of medical cannabis products.

Managing Director, Fleta Solomon believes the strict growing and manufacturing conditions applicable to local suppliers will ultimately give Australian medical cannabis the edge over international competitors, many of which are subject to less stringent quality and manufacturing standards.

Little Green Pharma’s goal is to make clean and natural, Australian-grown and medical grade medical cannabis products to supply both the Australian and overseas markets in 2019.

You might also be interested in

Fleta Solomon MD green polo

Insights

Big plans for Little Green Pharma

Read more on the Australian firm hoping to help more UK patients benefit from medical cannabis.

Apr 2020

First australian medical cannabis

Company news

First Australian-grown cannabis medicines

Little Green Pharma (LGP), is the first Australian company to locally-grow and produce medicinal cannabis products for sale to Australian patients. The first products are now ready to be delivered to patients.

Aug 2018

Researcher viewing cannabis

Insights

Little Green Pharma Stands Out Amid The Crowded Cannabis Canopy

Little Green Pharma (ASX:LGP) has some genuine pioneering notches on its belt. Read the article here

May 2020

View all articles